Elevance Health
ELV
706 hedge funds and large institutions have $30.4B invested in Elevance Health in 2014 Q3 according to their latest regulatory filings, with 67 funds opening new positions, 221 increasing their positions, 308 reducing their positions, and 42 closing their positions.
60% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 42
36% more call options, than puts
Call options by funds: $420M | Put options by funds: $309M
14% more capital invested
Capital invested by funds: $26.8B → $30.4B (+$3.62B)
3% more funds holding
Funds holding: 686 → 706 (+20)
10% less funds holding in top 10
Funds holding in top 10: 39 → 35 (-4)
28% less repeat investments, than reductions
Existing positions increased: 221 | Existing positions reduced: 308
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$389M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$169M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$116M |
| 4 |
VAM
Visium Asset Management
New York
|
+$112M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$270M |
| 2 |
First Eagle Investment Management
New York
|
-$165M |
| 3 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$116M |
| 4 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$95.1M |
| 5 |
SCM
Sterling Capital Management
Charlotte,
North Carolina
|
-$85.8M |
ELV Hedge Fund Activity: Q3 2014 in Review
706 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q3 2014, worth a combined $30.4B — up 14% from $26.8B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new ELV positions and 42 closed out — a net gain of 25 holders — while 221 added to existing stakes and 308 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $389M. The largest seller was Norges Bank, cutting an estimated $270M.
- 706 institutional investors held Elevance Health (ELV) as of Q3 2014, up from 686 in Q2 2014.
- Funds reported $30.4B of Elevance Health stock for Q3 2014, up 14% quarter-over-quarter.
- 67 funds opened new Elevance Health positions in Q3 2014 and 42 closed out, a net change of +25 holders.
- The largest Elevance Health buyer in Q3 2014 was AllianceBernstein, an estimated $389M added.
- The largest Elevance Health seller in Q3 2014 was Norges Bank, an estimated $270M sold.
Based on aggregated 13F filings for Q3 2014.